Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00106015 · ClinicalTrials.gov registry record
Diamond Blackfan Anemia Registry (DBAR)
A clinical trial of Anemia and Blood Disease, sponsored by Northwell Health.
- Recruiting
- Registry status
- 900
- Enrollment target
- 1
- Study location
NCT00106015: Recruiting study of Anemia and Blood Disease, sponsored by Northwell Health.
NCT00106015 is a study of Anemia and Blood Disease that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 900 participants, above the 415-participant average among 72 other Anemia trials with a reported enrollment target (117% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00106015, a study of Anemia and Blood Disease, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- 900 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to maintain a comprehensive registry of patients with the rare inherited bone marrow failure syndrome Diamond Blackfan anemia (DBA).
Primary Outcome
Epidemiology
Conditions Studied
Study Locations (1)
New York
- Cohen Children's Medical Center of NY - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2004-09 |
| Est. Completion | 2026-04 |
What NCT00106015 shows while recruiting
NCT00106015 is an observational study that tracks outcomes without assigning an intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 415-participant average among 72 other Anemia trials with a reported enrollment target (117% higher).
The record links to 2 conditions, with Anemia appearing as the primary indexed condition, and to 0 interventions.
NCT00106015 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00106015 about?
NCT00106015 is a clinical study titled "Diamond Blackfan Anemia Registry (DBAR)". The purpose of this study is to maintain a comprehensive registry of patients with the rare inherited bone marrow failure syndrome Diamond Blackfan anemia (DBA).
What is the current status of trial NCT00106015?
This trial is currently recruiting. The enrollment target is 900 participants. The study started on 2004-09. Estimated completion is 2026-04.
What conditions does trial NCT00106015 study?
This clinical trial studies the following conditions: Anemia, Blood Disease.
Who is sponsoring clinical trial NCT00106015?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00106015 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00106015's enrollment target sits among peer trials
900 9th of 72 higher than 64 of 72 other Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
-
Study of DISC-0974-201 in Participants With IBD and Anemia
RECRUITING · Phase 2
-
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RECRUITING · Phase 1
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RECRUITING · Phase 3
-
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia